Back to top

United Therapeutics acquires Thymmune Therapeutics

United Therapeutics (UTHR) has acquired Thymmune Therapeutics, a privately held, preclinical stage biotechnology company developing scalable, regen...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

United Therapeutics Corporation (UTHR)